Rick Simpson Oil (RSO) in Bermuda: The Complete Guide by OilWell Cannabis

Introduction: Why RSO Matters to Bermuda

If you’re reading this in Bermuda—whether you’re a longtime resident in Paget, a family in Hamilton Parish caring for a loved one, or a veteran in St. George’s searching for relief—you’ve likely heard whispers about Rick Simpson Oil. Maybe you encountered the term online while researching cancer support options. Perhaps a neighbor mentioned it at a cricket match. Or maybe you’re one of the many Bermudians dealing with chronic pain, PTSD, or insomnia who has grown frustrated with conventional treatments that seem to offer more side effects than solutions.

We understand. In an island community as close-knit as Bermuda’s, where everyone seems to know someone battling cancer or struggling with chronic pain, the search for effective relief becomes deeply personal. When King Edward VII Memorial Hospital provides excellent care but can’t always offer the holistic options you seek, when the cost of healthcare in Bermuda strains already tight budgets, and when traditional Bermudian stoicism meets the reality of suffering—you start looking elsewhere.

That’s where we come in. We’re OilWell Cannabis, a Houston-based company founded not in a corporate boardroom, but in the crucible of real suffering and desperate love. Our story begins with a paralyzed dog named Bentley facing euthanasia, evolves through a founder’s personal battle with PTSD and benzodiazepine addiction, and has grown into something that can now serve Bermudians seeking honest, science-based cannabinoid medicine.

This guide is our promise to you, Bermuda: no snake oil, no false hope, just the most comprehensive, evidence-grounded RSO education available anywhere—adapted specifically for your island home, your legal landscape, and your community’s needs.

Understanding Rick Simpson Oil: What Bermudians Need to Know

Who Was Rick Simpson, Really?

Rick Simpson was a power engineer from Amherst, Nova Scotia—not a doctor, not a scientist, not a medical professional. He was a blue-collar tradesman, much like many Bermudians who work with their hands and trust practical solutions over pharmaceutical complexity. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury that left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine failed to resolve.

Sound familiar, Bermuda? How many of you have been told by specialists overseas or local physicians that you’ll just have to “live with” chronic pain? How many have been prescribed medications that made things worse, not better? Simpson’s doctor refused to discuss cannabis as an option—even when Simpson reported it was the only thing helping. That dismissal, that failure of the medical system to listen, is a universal experience that resonates across the Atlantic to our shores here in Bermuda.

Simpson’s pivotal moment came in 2003 when three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions. According to his personal testimony, the bumps disappeared within four days. Important context: No independent medical verification exists. No biopsy confirmation was published. No peer-reviewed documentation ever appeared. This is personal testimony, not medical evidence—but it became the catalyst for a global movement.

The Crusade: From Nova Scotia to Bermuda’s Shores

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil, giving it away for free to cancer patients and others in his community. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more. In 2005, his story reached global audiences through the documentary Run From The Cure, which became foundational in cannabis communities worldwide.

The Royal Canadian Mounted Police raided his property in 2005 and again in 2009. He faced cultivation, possession, and trafficking charges. Eventually, he left Canada for Europe, continuing his advocacy from Croatia and the Netherlands. In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his platform.

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. He helped create the conditions for today’s legal cannabis industry, and the term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: His cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential—something we take deadly seriously for Bermudians facing cancer diagnoses.

The Traditional RSO Protocol: A 60-Gram, 90-Day Regimen

Many Bermudians searching online find Simpson’s specific dosing protocol. We present it here completely—not as a recommendation, but as education, because you deserve to know what you’re researching.

The Goal: Consume 60 grams of concentrated, high-THC cannabis oil over approximately 90 days.

Week 1: Begin with a dose the size of half a grain of dry rice—roughly 10-15mg of oil—taken three times daily (morning, afternoon, before bed). Total daily intake: ~30-45mg.

Weeks 2-5: Double the dose approximately every four days. By week five, target approximately 1 gram (1,000mg) of oil per day, divided into three roughly equal doses.

Weeks 5-12: Maintain 1 gram per day, divided into three ~333mg doses, until all 60 grams are consumed.

Administration Methods: Simpson recommended sublingual/oral as primary, topical for skin cancers, and acknowledged inhalation for symptom relief but not as primary treatment.

Critical Context for Bermuda: This protocol was designed for crude, single-strain extract with unknown potency. At peak dosing, patients consumed roughly 600-900mg of delta-9 THC daily—a dose far exceeding anything studied clinically. The risks are real: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. There are no controlled trials validating this protocol. Every batch of traditional RSO was different—no standardization, no lab testing, no contaminant screening.

What Traditional RSO Actually Was

For Bermudians considering products labeled “RSO” locally or online, here’s what Simpson’s original product actually was:

Source Material: Single high-THC indica strain, no standardization. Every batch varied by growing season and availability.

Extraction Solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol—neither food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete solvent purging is difficult to verify without lab testing.

Appearance: Nearly black, thick, tar-like oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile: 60-90% delta-9 THC (estimated, never lab-verified), fully decarboxylated. Minor cannabinoids present at natural ratios but uncontrolled, unmeasured.

Terpene Content: Minimal to none—destroyed by high-heat evaporation.

Standardization: None. Every batch different. No Certificate of Analysis. No contaminant screening.

Residual Solvent Risk: Significant. Modern extraction uses food-grade ethanol or CO₂ with validated testing. Traditional RSO carried real health risks from solvent residues.

Simpson’s Claims vs. The Evidence Record

We owe Bermuda the truth, no matter how difficult.

What the preclinical literature shows: In vitro studies demonstrate THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition. These findings generate legitimate scientific interest.

What it does NOT show: These findings have not translated into proven human cancer cures. The gap between lab results and human outcomes is vast. No human clinical trial has demonstrated RSO or any cannabis oil cures cancer.

Institutional Positions:

• U.S. National Cancer Institute: Acknowledges anticancer research but does not endorse cannabis as cancer treatment.
• FDA: Has not approved any cannabis plant product for cancer. Only Epidiolex (CBD for seizures) and synthetic THC analogues for chemo nausea and HIV/AIDS wasting are approved.
• Health Canada: Never approved RSO or cannabis oil as cancer cure.
• NCCIH: Strongest evidence is for epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure.

The Harm of Overstatement: Encouraging cancer patients to rely on RSO instead of proven therapies carries genuine harm potential. Delayed treatment for treatable cancers is a documented concern. We will never tell a Bermudian cancer patient to choose RSO over oncologic care.

The OilWell Cannabis Story: From a Dog Named Bentley to Bermuda’s Shores

Our Origin: Love, Desperation, and a Question That Changed Everything

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But Colin’s story begins far from Texas—in McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa Borderplex is one of the most economically challenged and dangerous regions along the U.S.-Mexico border, much like how some underserved communities in Bermuda face their own challenges despite the island’s overall prosperity.

Colin’s childhood was marked by violence, poverty, and loss. By sixteen, he’d seen friends killed or imprisoned. He had to leave home for good. He chose cannabis over darker paths, learning the plant intimately while operating in the shadows before legalization.

Later, he became a formally trained software engineer, doing custom development work for Baylor College of Medicine—one of America’s most prestigious medical institutions. That combination of deep plant knowledge and medical-grade technical precision defines everything we do.

But our real origin isn’t in code or cannabis—it’s in a dog named Bentley.

Bentley was family. When veterinarians delivered the verdict no pet owner wants to hear—euthanasia was the only humane option for his paralysis—Colin refused to accept it. The pain medications would destroy Bentley’s organs. The choice seemed to be painful decline or immediate mercy.

In desperation, a rescue worker named Jessica asked the question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had never explored cannabis therapeutically. He created CBD golden paste—a specialized cannabinoid formula for pets. The results were nothing short of miraculous. Bentley, paralyzed and facing death, got up and brought Colin his ball to play. This wasn’t placebo—dogs don’t respond to placebo. This was cannabinoid medicine succeeding where pharmaceuticals failed.

Ten Years of Formulation: Bentley Lived to 20

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia led to CBC’s role in neurogenesis
• Glaucoma led to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Battle: PTSD and Benzo Addiction

Colin knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat notoriously difficult and dangerous—using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This isn’t theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

From McAllen to Bermuda: Our Mission

Bentley’s journey was Colin’s entry into cannabis beyond getting high. It became a mission to create real solutions that alleviate pain and suffering—not just for pets, but for people. We’ve developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. Our focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

As Colin said in that first ABC13 feature in September 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That philosophy—honest education, not hype—guides every word we write for you, Bermuda.

The OilWell RSO Philosophy: Four Principles for Bermuda

Our RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways that solve problems that limited Simpson’s original vision.

1. Accessibility Over Gatekeeping

In Bermuda, accessing medical cannabis is frustrating. The Medicinal Cannabis Act 2016 created a legal framework, but implementation has been slow. As of 2024, only a handful of patients have been approved. You need a specialist’s recommendation, must suffer from specific qualifying conditions, and face bureaucratic hurdles that can feel insurmountable.

We take a different approach: No medical card required. Age 21+ only. We ship nationwide across the United States and internationally to Bermuda—provided you verify local legality and accept customs responsibility.

Simpson believed medicine should be accessible to everyone. We’ve built a product and distribution model that makes that accessible legally, even to island communities like Bermuda where traditional access is limited.

2. Patient-Controlled Potency

Bermuda’s conservative social environment means many residents need functional daytime relief without impairment. Our THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency.

This is crucial for Bermudians who:

• Work in finance or tourism and cannot be impaired during business hours
• Drive Bermuda’s narrow roads and need to remain sharp
• Prefer to function normally during the day while managing pain or anxiety
• Want the option of stronger relief at night for sleep

Simpson believed patients should control their medicine. We engineered a product that puts that control in your hands through chemistry, not rhetoric.

3. Open-Source Formulas

In Bermuda’s high-cost environment, we know not everyone can afford premium products. That’s why we publish our complete formulas publicly—every cannabinoid, every milligram, every percentage.

If you cannot afford $129.99 for our sublingual oil or $49.99 for our vape cartridge, you can source the individual cannabinoid distillates and make your own version. This is a direct echo of Simpson’s free-distribution ethos, adapted for the modern cannabinoid marketplace.

4. Evidence-Informed, Not Evidence-Overstating

Bermuda has a well-educated population. You deserve honesty, not hype. The GENERERAL KNOWLEDGE section of this document represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature. We have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

Legal Framework: RSO and Bermuda’s Cannabis Laws

Bermuda’s Legal Status:

Bermuda decriminalized possession of small amounts of cannabis (up to 7 grams) in 2017. This means possession results in civil penalties (fines) rather than criminal charges, but recreational use remains illegal.

The Medicinal Cannabis Act 2016 legalized medical cannabis, but implementation has been extremely limited. As of early 2024, only a handful of patients have been approved through the Bermuda Cannabis Licensing Authority. The program requires:

• Specialist physician recommendation
• Specific qualifying conditions (cancer, HIV/AIDS, glaucoma, etc.)
• Strict regulatory compliance
• Limited product availability

OilWell Products and Bermuda:

Our RSO products are Farm Bill compliant in the United States, containing less than 0.3% delta-9 THC. However, Bermuda residents must understand:

1. Importation: Our products ship internationally, but you accept all customs and legal responsibility. Bermuda Customs may inspect packages.
2. Local Legality: While hemp-derived products may fall into a gray area, Bermuda law enforcement could interpret them as cannabis products. The decriminalization threshold is 7 grams of plant material—oils and extracts are not specifically addressed.
3. THCa Conversion: If you decarboxylate our product (converting THCa to delta-9 THC), you may exceed local legal thresholds for psychoactive cannabis.
4. Customer Responsibility: You must verify Bermuda’s current laws before ordering. We provide full documentation, Certificates of Analysis, and receipts, but you assume all legal risk.

Important Legal Notice: OilWell ships with complete documentation, but Bermuda customers are responsible for understanding and complying with local laws. We assume no liability for customs seizures or legal issues in Bermuda. Always verify current regulations with Bermuda’s Attorney General’s Chambers or the Cannabis Licensing Authority.

The Formulas: Complete Specifications for Bermuda

We publish our exact formulas because you deserve transparency. Here’s what you’re getting:

RSO Sublingual Oil — $129.99

Cannabinoid Content (per 30mL bottle):

• CBD: 4,500mg
• CBG: 3,000mg
• Delta-8 THC: 6,000mg
• THCa: 1,500mg
• Delta-9 THC: 90mg
• CBN: 750mg
• CBC: 750mg
• Total Cannabinoids: 16,590mg (553mg/mL)

Terpene Profile (5% live terpenes):

• Limonene (citrus-bright)
• Myrcene
• Caryophyllene (pepper/spice)
• Pinene (forest-fresh)
• Linalool (lavender-floral)
• Humulene (earthy-woody)
• Terpinolene (piney-fruity)

Base: Organic MCT oil
Dosing: Graduated dropper with 0.1mL increments
Onset: 15-45 minutes (sublingual)
Duration: 4-6 hours
Bioavailability: 13-19%
Approximate doses per bottle: 40-60 (depending on serving size)

RSO Vape Cartridge — $49.99

Cannabinoid Content (1g cartridge):

• CBD: 30%
• CBG: 20%
• Delta-8 THC: 15%
• THCa: 10%
• CBN: 10%
• CBC: 10%
• Total Cannabinoids: 900mg+

Terpene Profile: 5%+ live terpenes (same seven-terpene blend)
Battery: 510-thread universal compatibility
Onset: 1-2 minutes (fastest delivery)
Duration: 2-4 hours
Bioavailability: 10-35%

When to Use Each Format in Bermuda

Situation	Recommended Format	Why It Works for Bermuda Life
Acute pain flare-up while working	Vape	1-2 minute onset means you can address pain quickly during a busy workday in Hamilton or at a tourism site
Sustained relief for chronic conditions	Sublingual	4-6 hour duration supports you through a full day without re-dosing
Need maximum absorption	Sublingual	Higher bioavailability means more cannabinoids reach your system—important when every dollar counts in Bermuda’s economy
Discreet use in public	Vape	Compact and subtle for use anywhere from Horseshoe Bay to Front Street
Precise dosing for medical needs	Sublingual	Graduated dropper allows exact measurement—crucial for titrating your ideal dose
Daytime functional relief	Sublingual (raw)	Zero psychoactive impairment lets you drive, work, and socialize normally
Nighttime sleep support	Sublingual (decarbed) or Vape	CBN at 750mg plus activated THC promotes rest in Bermuda’s quiet nights

The Decarboxylation Choice: Your Power in Bermuda

Traditional RSO was always psychoactive. Our formula gives you control—critical in a community like Bermuda where professional reputation matters.

Option 1: Raw (Non-Psychoactive)

• All 1,500mg THCa stays acidic
• No high, no impairment
• Use during Bermuda’s business hours, while sailing, or anytime you need clarity
• Anti-inflammatory benefits via COX-2 inhibition and PPARγ agonism

Option 2: Fully Activated (Home Decarboxylation)

• Heat oil at 260°F (125°C) for 45-60 minutes in oven-safe glass
• 1,500mg THCa converts to ~1,315mg delta-9 THC
• Total delta-9 THC: ~1,405mg + 6,000mg delta-8 THC = psychoactive potency comparable to traditional RSO
• Legal because you activate it yourself after legal purchase

Option 3: Instant Activation (Vape)

• Vaping at 400-450°F auto-decarboxylates THCa with each puff
• Fastest relief for acute breakthrough symptoms

Conversion Math: 1mg THCa = 0.877mg delta-9 THC after decarboxylation

The Science Behind Every Cannabinoid: Evidence for Bermuda

CBD (4,500mg in sublingual oil)

What Bermuda should know: This is our most evidence-developed cannabinoid.

Best supported uses:

• Seizure disorders: FDA-approved Epidiolex for specific epilepsies [2]
• Anxiety: 2024 meta-analysis of 316 participants showed significant anxiolytic signal [3]
• Chronic pain: 2024 systematic review found promising but heterogeneous results [4]

Safety: 2023 meta-analysis identified liver enzyme elevation risk, especially important for Bermudians taking multiple medications [6]. NCCIH flags diarrhea, sleepiness, appetite changes, and drug interactions [1].

Bermuda relevance: For islanders dealing with chronic pain without wanting opioids, CBD offers a non-intoxicating option with the strongest human evidence base.

CBG (3,000mg)

What Bermuda should know: Promising but still preclinical-dominant.

Pharmacology: CBG is the biosynthetic precursor to major cannabinoids. It interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling [7].

Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity—but these are preclinical hypotheses, not proven treatments [7][8].

Bermuda relevance: For Crohn’s or IBS patients in Bermuda seeking alternatives, CBG is interesting but experimental. We include it for potential synergy, not as a standalone treatment.

Delta-8 THC (6,000mg)

What Bermuda should know: Psychoactive, less potent than delta-9, but not “mild.”

Pharmacology: Partial CB1 agonist with cannabinoid-mimetic activity [9]. Less potent than delta-9 THC due to weaker CB1 affinity [9].

Safety concerns: 2023 scoping review found adverse consequence reports and emphasized regulatory concerns [10]. Manufacturing quality varies significantly [11].

Bermuda relevance: Provides psychoactive relief while staying within U.S. legal limits. For Bermudians seeking symptom relief beyond what CBD offers, delta-8 is a middle ground—stronger than CBD but different from delta-9.

THCa (1,500mg)

What Bermuda should know: Your key to choice.

Non-psychoactive: Does not produce THC’s high unless heated [12].

Potential benefits: Preclinical studies suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities [12].

Bermuda relevance: This is how you can legally import a product that becomes high-potency medicine only if you choose to activate it. For daytime use in Bermuda’s professional environment, raw THCa provides benefits without impairment.

Delta-9 THC (90mg)

What Bermuda should know: Strongest psychoactive, clearest therapeutic evidence—and risks.

Best supported uses: Chemo nausea, HIV/AIDS appetite, some pain and MS symptoms [1].

Safety: 2025 systematic review of high-concentration THC found consistent associations with psychosis, schizophrenia, cannabis use disorder, anxiety, and depression [15]. Also causes tachycardia, blood pressure changes, dependency [1].

Bermuda relevance: Our 90mg total is dramatically lower than Simpson’s 600-900mg daily dose. When activated via decarboxylation, you gain potency comparable to traditional RSO while maintaining initial legal compliance.

CBN (750mg)

What Bermuda should know: Marketing has outrun evidence.

Sleep claims: 2021 narrative review screened 99 human-study abstracts and found NO clinical trials using validated sleep questionnaires or polysomnography that substantiate strong sleep-promoting claims [16].

2024 update: Cannabis and sleep review concluded research still doesn’t match real-world use, needing better-designed trials [17].

Bermuda relevance: We’re honest: CBN is included based on its theoretical potential and your feedback, not robust clinical proof. Start with realistic expectations.

CBC (750mg)

What Bermuda should know: Emerging, intriguing, preclinical-dominant.

Pharmacology: Distinct from THC and CBD, with potential antinociceptive, antibacterial, and anti-seizure applications [18].

Research: 2024 review noted CBC is already sold over-the-counter despite little established clinical efficacy or safety data [18].

Bermuda relevance: Another minor cannabinoid where science is promising but unproven. We include it for potential entourage effects [19].

The Science Behind Every Terpene: Bermuda’s Full Profile

Limonene (Citrus-Bright)

What Bermuda should know: Multifunctional but mostly preclinical.

Potential: Anti-inflammatory, antioxidant, cardioprotective, gastroprotective [21].

Allergy caution: Limonene hydroperoxides are contact allergens [22].

Bermuda connection: That bright citrus aroma pairs perfectly with Bermuda’s sunshine and ocean air—refreshing and uplifting.

Myrcene

What Bermuda should know: Sedation claims lack human proof.

Research: 2021 review found anxiolytic, anti-inflammatory, analgesic properties but explicitly stated human studies are lacking [23].

Bermuda connection: Often associated with “couch-lock,” but that’s more folklore than science. Enjoy the herbal notes without overestimating effects.

Caryophyllene (Pepper/Spice)

What Bermuda should know: Most cannabinoid-relevant terpene.

Unique factor: Selective CB2 receptor agonist [24].

Potential: Anti-inflammatory, neuroprotective, gastroprotective [24].

Bermuda connection: The peppery spice note adds complexity to our flavor profile and may work synergistically with cannabinoids for inflammation.

Pinene (Forest-Fresh)

What Bermuda should know: Brain-health interest but limited human trials.

Potential: Antioxidant, anti-inflammatory, neuroprotective [25].

Bermuda connection: That fresh pine scent reminiscent of Bermuda’s casuarina trees—clarifying and clean.

Linalool (Lavender-Floral)

What Bermuda should know: Calming potential but clinical proof limited.

Research: 2022 review discussed antidepressant mechanisms but noted need for human trials [26].

Allergy caution: Oxidized linalool is a contact allergen [22].

Bermuda connection: The floral notes evoke Bermuda’s hibiscus and oleander—calming and familiar.

Humulene (Earthy-Woody)

What Bermuda should know: Promising preclinical, not clinically settled.

Potential: Rodent studies suggest cannabimimetic properties via CB1 and adenosine A2a pathways [27].

Bermuda connection: Earthy notes ground the formulation, connecting you to Bermuda’s natural landscape.

Terpinolene (Piney-Fruity-Sparkling)

What Bermuda should know: Most underdeveloped terpene here.

Research: 2021 systematic review of 2,449 records found mostly in silico, in vitro, and animal studies [28].

Bermuda connection: The complex, sparkling finish to our terpene profile—unique and intriguing.

Evidence Standards: Then and Now

Rick Simpson operated pre-legalization, pre-testing, pre-peer-review. His evidence was anecdotal. We operate post-legalization, with full lab testing, and access to 29 peer-reviewed citations [1]-[29].

How we evaluate claims:

1. Human clinical evidence first
2. Systematic reviews and meta-analyses
3. NIH and institutional summaries
4. Preclinical/mechanistic literature when human data is sparse

For Bermuda, this means: When we say something works, we tell you exactly how strong the evidence is. When we say something is promising but unproven, we say that clearly. Your health decisions deserve nothing less.

Common Overstatements We Refuse to Make (For Bermuda’s Sake)

Overstatement: CBN is a proven sleep aid.
Truth: No clinical trials with validated sleep measures support this [16][17].

Overstatement: Myrcene will make you sedated or cause “couch-lock.”
Truth: Human proof for this common claim is limited [23].

Overstatement: Terpenes have proven entourage effects in humans.
Truth: Hypotheses are promising but clinical proof remains limited [20][29].

Overstatement: THCa is always non-psychoactive.
Truth: Heating converts it to psychoactive THC [12].

Overstatement: Delta-8 is safe because it’s hemp-derived.
Truth: It’s psychoactive with less robust safety data than delta-9 [9]-[11].

Condition-Specific Usage for Bermuda Residents

Important Disclaimer: Not medical advice. Not FDA-approved. Not a substitute for professional care. Consult your physician, especially at King Edward VII Memorial Hospital or your overseas specialist. Do not operate vehicles or machinery while impaired.

Chemotherapy-Related Nausea & Appetite Support

Bermuda context: Many Bermudians receive cancer treatment overseas or locally. Our formula supports you through that journey.

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for 1-2 minute relief
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)

Chronic Pain (Arthritis, Fibromyalgia, Neuropathy)

Bermuda context: Whether it’s joint pain keeping you from golfing at Riddell’s Bay or back pain from working on boats, we understand.

• Daytime: 0.3-0.5mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual—pain relief plus sleep support
• Breakthrough pain: Vape as needed for rapid onset

Sleep Support

Bermuda context: Island life’s stress can disrupt sleep. Our formula addresses this naturally.

• Before bed: 1.0-2.0mL sublingual delivers 25-50mg CBN
• At 2.0mL: This is the dosage level investigated in 2024 sleep literature
• Reality check: CBN evidence is weak, but many users report benefits

Anxiety & Stress

Bermuda context: High cost of living, small-community pressures, and hurricane season stress affect many.

• Daytime functional relief: 0.3mL raw sublingual—CBD and CBG without impairment
• Nighttime: 1.0mL sublingual—full profile including CBN

Titration Principle for Bermuda: Start Low, Go Slow

Begin with 0.25-0.5mL sublingual. Assess effects over 2-3 hours before increasing. Bermuda’s slower pace of life actually supports this careful approach.

Delivery to Bermuda: How to Access Our Products

International Shipping to Bermuda

We ship to Bermuda. Here’s exactly how it works:

Shipping Method: USPS Priority Mail International or FedEx International Economy
Delivery Time: 7-14 business days to Hamilton, St. George’s, or any Bermuda address
Packaging: Discreet, no cannabis branding visible, temperature-stable for ocean transit
Documentation Included:

• Full Certificate of Analysis (COA)
• Itemized receipt
• Farm Bill compliance statement
• Hemp-derived product declaration

Cost: Minimum flat-fee shipping applies (typically $35-50 USD). Excessive costs are billed to you.
Customs: You accept all customs responsibility. Bermuda Customs may inspect packages.
Tracking: Provided for all orders
Signature: Required upon delivery

Legal Responsibility: We provide documentation showing <0.3% delta-9 THC content, making it a hemp product under U.S. law. However, Bermuda’s customs authorities may interpret products differently. You must verify current Bermuda law before ordering.

Contact for Bermuda Orders:

• Phone: (832) 416-2816 (please note time zone difference: Houston is 2 hours behind Bermuda)
• Email: [email protected]
• Website: oilwellcbd.com

Why This Matters for Bermuda: Rick Simpson couldn’t ship his oil anywhere—it was Schedule I globally. Today, a Bermudian cancer patient, chronic pain sufferer, or veteran can legally access the same clinical-strength multi-cannabinoid RSO formula that Houstonians receive via same-day delivery. We’ve completed a piece of Simpson’s vision that prohibition made impossible.

Media Recognition: Why Bermuda Can Trust Our Voice

Between September 2019 and April 2023, ABC13 Houston—America’s fourth-largest city—featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across four years. No other Houston cannabis operator matches this frequency or breadth.

Our Seven ABC13 Features

1. September 15, 2019: “Texas CBD businesses booming”
The moment that launched everything. Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot…”

2. March 22, 2021: “Entrepreneur creates direct-to-consumer business”
Colin’s therapy quote: “People think that everyone just wants to get high… but people are looking for things to help them with real pain. Pain comes in a lot of different forms.” This resonates across cultures—from Houston’s working class to Bermuda’s maritime community.

3. May 24, 2021: “What is Delta 8 THC”
Steve Campion’s investigation of “legal weed.” Colin’s iconic honesty: “Maybe you want to get high.” This uncensored truth-telling on mainstream TV established our reputation for radical transparency.

4. August 20, 2021: “Houston CBD shop giving away free products for COVID vaccine”
We gave away 1,000 caviar pre-rolls (~$35,000 in product) to encourage vaccination. We coordinated with Houston city government, no political strings attached. Community action is our DNA.

5. October 19, 2021: “Texas ban over Delta 8”
When Texas reclassified Delta-8 as Schedule I overnight, we proactively removed all products before enforcement. We warned other operators who were unknowingly shipping Schedule I narcotics. Ethical leadership during crisis.

6. October 7, 2022: “Biden marijuana pardon”
Colin revealed his personal marijuana conviction history: “You face challenges with housing, loans, and banking… I would love to see people not get hurt for this anymore.” This transformed our media record—every quote carries more weight when you know the speaker has lived the consequences.

7. April 21, 2023: “Marijuana industry getting creative”
Colin grew hemp on camera: “Right now is actually a pretty Renaissance… time that should be enjoyed now.” Positioned at the frontier of legal cannabis evolution.

The Through-Line: These features document consistency across years, breadth of expertise, community action, personal stakes, and earned credibility. This is recognition that cannot be purchased—only earned through integrity.

Why OilWell’s Formulas Diverge from Traditional RSO: A Bermuda Perspective

Multi-Cannabinoid Approach

Traditional RSO relied on one strain. We include seven cannabinoids because the entourage-effect literature suggests potential benefit from diversity [20][29]. For Bermudians with complex conditions affecting multiple body systems, this breadth matters.

Terpene Preservation

Traditional RSO destroyed terpenes. We include 5% live terpenes because preclinical evidence supports their bioactivity [20]-[28]. For Bermuda’s aromatherapy-aware population, this adds sensory dimension and potential synergy.

THCa as Separate Ingredient

Traditional RSO was fully decarboxylated. We preserve 1,500mg THCa because its non-psychoactive bioactivity is relevant for daytime Bermuda lifestyles [12].

Reduced Delta-9 THC Dominance

Traditional RSO was 60-90% delta-9 THC. Our formula uses only 90mg total delta-9 THC, distributing potency across multiple cannabinoids—reducing adverse-effect risk while maintaining therapeutic potential.

Product Format Innovation

Traditional RSO had one crude oil. We offer sublingual oil for sustained relief and vape for breakthrough symptoms—adapting to Bermuda’s varied needs.

Our Broader Product Portfolio (Available to Bermuda)

Beyond RSO, we create targeted formulas:

Asshole Peach — Our most popular product, particularly favored by veterans for PTSD and pain relief without over-sedation.

Peace Gummies — Born from Colin’s benzo withdrawal experience. Available in gummy and vape forms for anxiety and sleep.

Custom Creations — We design tailored products for specific cannabinoid ratios, delivery formats, or health circumstances (vegan, diabetic, unique needs).

Practical Takeaways for Bermuda: The Bottom Line

1. CBD and delta-9 THC have the strongest human evidence in these formulas.
2. Delta-8 THC is not trivial—it’s psychoactive with real but less-studied effects.
3. THCa changes with heating—your choice matters legally and experientially.
4. CBG, CBN, CBC are promising but clinically immature—manage expectations.
5. Terpenes are interesting but claims should be conservative until human proof strengthens.

How Bermuda Residents Can Order

1. Visit oilwellcbd.com
2. Select RSO Sublingual Oil ($129.99) or Vape Cartridge ($49.99)
3. Verify Bermuda’s current cannabis laws
4. Checkout with your Bermuda shipping address
5. Receive tracking information (7-14 day delivery)
6. Accept customs responsibility and signature requirement
7. Contact us with questions: (832) 416-2816 or [email protected]

References for Bermuda Readers

The following peer-reviewed citations support every claim in this document. No other RSO company provides this level of scientific transparency.

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH.
2. Talwar A, et al. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy. Exp Neurol. 2023.
3. Han K, et al. Therapeutic potential of cannabidiol CBD in anxiety disorders. Psychiatry Res. 2024.
4. Cásedas G, et al. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in pain. Pharmaceuticals. 2024.
5. Ranum RM, et al. Use of cannabidiol in insomnia. Cannabis Cannabinoid Res. 2023.
6. Lo LA, et al. Cannabidiol-associated hepatotoxicity. J Intern Med. 2023.
7. Nachnani R, et al. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021.
8. Li S, et al. Cannabigerol CBG: Comprehensive review. Molecules. 2024.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol. Br J Pharmacol. 2022.
10. LoParco CR, et al. Delta-8 tetrahydrocannabinol: A scoping review. Addiction. 2023.
11. Abdel-Kader MS, et al. Chemistry and pharmacology of Delta-8-THC. Molecules. 2024.
12. Moreno-Sanz G. Critical review of THCa. Cannabis Cannabinoid Res. 2016.
13. McDonagh MS, et al. Cannabis-based products for chronic pain. Ann Intern Med. 2022.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003.
15. Rittiphairoj T, et al. High-concentration delta-9-THC and mental health. Ann Intern Med. 2025.
16. Corroon J. Cannabinol and sleep. Cannabis Cannabinoid Res. 2021.
17. Lavender I, et al. Using cannabis and CBD to sleep. Curr Psychiatry Rep. 2024.
18. Sepulveda DE, et al. Potential of cannabichromene. J Pharmacol Exp Ther. 2024.
19. Zagožen M, et al. CBG and CBC in Cannabis sativa. Acta Pharm. 2021.
20. André R, et al. Entourage effect in cannabis. Pharmaceuticals. 2024.
21. Anandakumar P, et al. D-limonene: Multifunctional compound. J Food Biochem. 2021.
22. Ogueta IA, et al. Limonene and linalool hydroperoxides. Contact Dermatitis. 2022.
23. Surendran S, et al. Myrcene: Potential health benefits. Front Nutr. 2021.
24. Hashiesh HM, et al. Beta-caryophyllene as CB2 agonist. Biomed Pharmacother. 2021.
25. Weston-Green K, et al. Pinene and linalool for brain health. Front Psychiatry. 2021.
26. Dos Santos ÉRQ, et al. Linalool for depression. Curr Neuropharmacol. 2022.
27. Dalavaye N, et al. Clinical translation of alpha-humulene. Planta Med. 2024.
28. Menezes IO, et al. Terpinolene: Systematic review. Phytomedicine. 2021.
29. Russo EB. Taming THC: Entourage effects. Br J Pharmacol. 2011.

Final Thoughts for Bermuda

OilWell Cannabis is more than a brand. We are a promise to deliver the best, most thoughtful cannabis products available with integrity, creativity, and the mission that started when Bentley got up, walked across the room, and brought his ball to play.

For Bermuda, this means:

• Legal access to multi-cannabinoid RSO without medical gatekeeping
• Patient control over psychoactivity for your professional and personal needs
• Transparent formulas you can trust in a small community where reputation matters
• Honest education that respects your intelligence and your health challenges
• International shipping that brings Houston-quality products to your island doorstep

Whether you’re facing cancer, chronic pain, PTSD, or simply seeking better wellness options in Bermuda’s unique environment, we offer something no one else does: the complete formula, the complete science, and complete honesty.

Visit oilwellcbd.com today. Questions? Call (832) 416-2816 or email [email protected]. We’re here to help Bermuda discover what cannabinoid medicine can do—on your terms, with your control, and with our unwavering commitment to truth over hype.

OilWell Cannabis
810 Richmond Ave, Houston, TX 77006
Montrose, Houston, Texas
Texas DSHS Licensed
Near-5.0 Google Rating
Operating Since 2019
~$1M Annual Revenue

All artwork, formulations, and packaging created in-house in Houston.